English
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

hidradenitis suppurativa/headache

The link is saved to the clipboard
4 results

A preliminary report on the use of Staphage Lysate for treatment of hidradenitis suppurativa.

Only registered users can translate articles
Log In/Sign up
Eight patients, 7 with hidradenitis suppurativa and 1 with chronic recurrent staphylococcal abscess, all of whom failed to respond to antibiotic therapy, conservative therapeutic measures, and surgery, were experimentally placed on Staphage Lysate. Treatment after appropriate skin testing consisted

Infliximab for the treatment of hidradenitis suppurativa.

Only registered users can translate articles
Log In/Sign up
BACKGROUND Hidradenitis suppurativa is a chronic inflammatory disease characterized by significant morbidity. Current medical therapies are usually only minimally effective. OBJECTIVE To assess the efficacy and safety of infliximab monotherapy for the treatment of severe extensive refractory forms

Successful control of hidradenitis suppurativa with verapamil: a case report.

Only registered users can translate articles
Log In/Sign up
An inappropriate immunologic response has been suggested to play a role in the pathogenesis of hidradenitis suppurativa (HS). Adalimumab was the first TNF-α inhibitor approved for moderate to severe HS. We report on a case of HS (Hurley stage 2) in a 39-year-old man, who had received fusidic acid

Apremilast for moderate hidradenitis suppurativa: Results of a randomized controlled trial.

Only registered users can translate articles
Log In/Sign up
BACKGROUND Effective anti-inflammatory treatments for hidradenitis suppurativa (HS) are limited. OBJECTIVE To evaluate the efficacy and short-term safety of apremilast in patients with moderate HS. METHODS A total of 20 patients with moderate HS were randomized in a 3:1 ratio to receive blinded
Join our facebook page

The most complete medicinal herbs database backed by science

  • Works in 55 languages
  • Herbal cures backed by science
  • Herbs recognition by image
  • Interactive GPS map - tag herbs on location (coming soon)
  • Read scientific publications related to your search
  • Search medicinal herbs by their effects
  • Organize your interests and stay up do date with the news research, clinical trials and patents

Type a symptom or a disease and read about herbs that might help, type a herb and see diseases and symptoms it is used against.
*All information is based on published scientific research

Google Play badgeApp Store badge